Cross-fund · 4 holders
ZBIO
ZENAS BIOPHARMA INC
CUSIP 98937L105
4
Tracked holders
$104.4M
Aggregate value
4,095,101
Shares
5
Active funds
Funds holding ZBIO
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $52.8M | — | +290,307 | +25.0% |
| BlackRock | Institutional | Q1 2026 | $39.8M | — | +270,030 | +15.3% |
| Millennium | Multi-Strategy | Q1 2026 | $9.3M | — | +427,658 | +869.9% |
| Citadel | Multi-Strategy | Q1 2026 | $2.5M | — | +70,911 | +124.9% |
| Point72FEAT | Multi-Strategy | Q1 2026 | — | — | −403,400 | EXITED |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.